Injection for arthritis. Close-up of a certolizumab pego injection being administered to treat a 77-year-old female patient with inflammatory arthritis. Certolizumab pegol (trade name Cimzia) is an injectable synthetic protein antibody that binds to a substance called tumour necrosis factor alpha (TNFa). TNFa is produced in the body during inflammation,and it promotes inflammatory processes. Certolizumab blocks its inflammatory effects in patients with rheumatoid arthritis and Crohn's disease | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Marazzi, Dr. P. |
Bildgröße: | 5166 px × 3448 px |
Modell-Rechte: | vorhanden |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: |
|